GlucoTrack, Inc.(GCTK)Earnings, Financials & Key Ratios
GCTK•NASDAQ
0.0× P/E·Price updated Jun 19, 2026
AboutGlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.Show more
- Revenue$0
- EBITDA-$15M-104.6%
- Net Income-$23M-218.4%
- EPS (Diluted)60.76+258.6%
GCTK Key Insights
GlucoTrack, Inc. (GCTK) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Weak momentum: RS Rating 2 (bottom 2%)
- ✗Shares diluted 79.1% in last year
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when GCTK posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
GCTK Price & Volume
GlucoTrack, Inc. (GCTK) stock price & volume — 10-year historical chart
Loading chart...
GCTK Growth Metrics
GlucoTrack, Inc. (GCTK) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-122.14%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-7.17%
Return on Capital
10 Years110.83%
5 Years-183.84%
3 Years-262.18%
Last Year-361.42%
GCTK Peer Comparison
GlucoTrack, Inc. (GCTK) competitors in Patient monitoring and respiratory care — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 DXCM | 27.96B | 72.47 | 34.67 | 15.6% | 19.31% | 33.83% | 0.51 | |
 PODD | 10.23B | 145.76 | 41.89 | 30.73% | 10.44% | 21.38% | 0.69 | |
 TNDM | 1.05B | 15.30 | -5.03 | 7.93% | -9.2% | -68.29% | 2.86 | |
 SENS | 281.69M | 6.74 | -4.06 | 56.89% | -214.16% | -130% | 0.68 | |
 NXTC | 5.41M | 2.02 | -0.10 | -186.96% | 0.12 | |||
 ABT | 153.68B | 88.38 | 11.57 | 4.59% | 31.88% | 27.26% | 0.32 | |
 LMAT | 2.14B | 93.95 | 37.28 | 13.53% | 24.35% | 16.19% | 0.47 | |
 INVA | 1.66B | 22.49 | 6.82 | 18.52% | 118.91% | 47.59% | 0.23 |
Compare GCTK vs Peers
GlucoTrack, Inc. (GCTK) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
GCTK Income Statement
GlucoTrack, Inc. (GCTK) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 611.69K | 589.46K | 43.49K | 208K | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue Growth % | 327.26% | -3.63% | -92.62% | 378.29% | -100% | - | - | - | - | - |
Cost of Goods Sold | 59.58K | 140.21K | 95.56K | 0 | 47K | 0 | 23K | 13K | 36K | 43K |
COGS % of Revenue | 9.74% | 23.79% | 219.75% | - | - | - | - | - | - | - |
Gross Profit | 552.11K▲ 0% | 449.25K▼ 18.6% | -52.08K▼ 111.6% | 208K▲ 499.4% | -47K▼ 122.6% | 0▲ 100.0% | -23K▲ 0% | -13K▲ 43.5% | -36K▼ 176.9% | -43K▲ 0% |
Gross Margin % | 90.26% | 76.21% | -119.75% | 100% | - | - | - | - | - | - |
Gross Profit Growth % | 461.79% | -18.63% | -111.59% | 499.42% | -122.6% | 100% | - | 43.48% | -176.92% | - |
Operating Expenses | 6.27M | 11.17M | 6.58M | -3.3M | 3.08M | 4.04M | 4.41M | 7.09M | 14.51M | 15.36M |
OpEx % of Revenue | 1024.63% | 1894.15% | 15135.41% | -1585.58% | - | - | - | - | - | - |
Selling, General & Admin | 3.31M | 7.85M | 3.48M | 2.06M | 1.58M | 2.12M | 2.46M | 2.4M | 5.03M | 6.57M |
SG&A % of Revenue | 540.6% | 1331.77% | 8005.08% | 992.31% | - | - | - | - | - | - |
Research & Development | 2.88M | 3.21M | 3.03M | 1.61M | 1.5M | 1.81M | 1.95M | 4.69M | 9.48M | 8.78M |
R&D % of Revenue | 471.12% | 544.13% | 6974.02% | 772.12% | - | - | - | - | - | - |
Other Operating Expenses | 78.89K | 107.55K | 67.98K | -6.97M | 0 | 110K | 0 | 0 | 0 | 0 |
Operating Income | 5.66M▲ 0% | 10.58M▲ 87.0% | 6.54M▼ 38.2% | 3.51M▼ 46.4% | -3.13M▼ 189.3% | -4.04M▼ 29.0% | -4.43M▼ 9.7% | -7.1M▼ 60.3% | -14.55M▼ 104.8% | -15.4M▲ 0% |
Operating Margin % | 924.63% | 1794.15% | 15035.41% | 1685.58% | - | - | - | - | - | - |
Operating Income Growth % | 21.49% | 86.99% | -38.17% | -46.38% | -189.33% | -28.99% | -9.7% | -60.29% | -104.77% | - |
EBITDA | 5.72M | 10.64M | 6.6M | 3.56M | -3.08M | -4M | -4.41M | -7.09M | -14.51M | -15.36M |
EBITDA Margin % | 934.37% | 1805.67% | 15170.6% | 1710.1% | - | - | - | - | - | - |
EBITDA Growth % | 21.6% | 86.23% | -38.02% | -46.08% | -186.73% | -29.59% | -10.28% | -60.83% | -104.64% | 28.37% |
D&A (Non-Cash Add-back) | 59.58K | 67.88K | 58.79K | 51K | 47K | 42K | 23K | 13K | 36K | 43K |
EBIT | -5.39M | -10.3M | -6.7M | -3.51M | -2.7M | -3.98M | -4.43M | -7.1M | -22.01M | -24.92M |
Net Interest Income | -15.59K | -27.43K | -17.36K | -10K | 98K | 26K | 8K | 7K | -583K | -543K |
Interest Income | 629 | 0 | 0 | - | 98K | 26K | 11K | 7K | 0 | 1.3M |
Interest Expense | 16.22K | 24.4K | 18.29K | 10K | 0 | 0 | 3K | 0 | 583K | 1.85M |
Other Income/Expense | 246.1K | 247.04K | -176.82K | -7.02M | 436K | -27K | -3K | 7K | -8.05M | -11.37M |
Pretax Income | -5.41M▲ 0% | -10.33M▼ 90.9% | -6.72M▲ 35.0% | -3.52M▲ 47.6% | -2.7M▲ 23.3% | -4.07M▼ 50.9% | -4.43M▼ 9.0% | -7.1M▼ 60.0% | -22.6M▼ 218.4% | -26.77M▲ 0% |
Pretax Margin % | -884.39% | -1752.24% | -15442.01% | -1690.38% | - | - | - | - | - | - |
Income Tax | 16.22K | 24.4K | -13.24M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Effective Tax Rate % | -0.3% | -0.24% | 197.09% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Net Income | -5.41M▲ 0% | -10.33M▼ 90.9% | -6.72M▲ 35.0% | -3.52M▲ 47.6% | -2.7M▲ 23.3% | -4.07M▼ 50.9% | -4.43M▼ 9.0% | -7.1M▼ 60.0% | -22.6M▼ 218.4% | -26.77M▲ 0% |
Net Margin % | -884.39% | -1752.24% | -15442.01% | -1690.38% | - | - | - | - | - | - |
Net Income Growth % | 7.4% | -90.93% | 34.98% | 47.64% | 23.32% | -50.85% | -9.05% | -60.02% | -218.4% | -122.14% |
Net Income (Continuing) | -5.41M | -10.33M | -6.72M | -3.52M | -2.7M | -4.07M | -4.43M | -7.1M | -22.6M | -26.77M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 0.00▲ 0% | 0.00▲ 0% | 0.00▲ 0% | -29.50▲ 0% | -17.88▲ 39.4% | -26.32▼ 47.2% | -28.66▼ 8.9% | -38.30▼ 33.6% | 60.76▲ 258.6% | -54.14▲ 0% |
EPS Growth % | - | - | - | - | 39.39% | -47.2% | -8.89% | -33.64% | 258.64% | -7.17% |
EPS (Basic) | 0.00 | 0.00 | 0.00 | -29.50 | -17.88 | -26.32 | -28.66 | -38.30 | 60.76 | - |
Diluted Shares Outstanding | 0 | 0 | 0 | 119.18K | 150.79K | 154.51K | 154.75K | 207.6K | 371.91K | 494.5K |
Basic Shares Outstanding | 0 | 0 | 0 | 119K | 150K | 154K | 154K | 185K | 371.91K | 494.5K |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
GCTK Balance Sheet
GlucoTrack, Inc. (GCTK) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 2.02M | 1.23M | 314.14K | 718K | 10.23M | 6.11M | 2.38M | 4.87M | 5.77M | 10.08M |
Cash & Short-Term Investments | 148.84K | 53.78K | 97.08K | 419K | 9.82M | 6.06M | 2.31M | 4.49M | 5.62M | 9.55M |
Cash Only | 148.84K | 53.78K | 97.08K | 419K | 9.82M | 6.06M | 2.31M | 4.49M | 5.62M | 9.55M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 92.06K | 121.78K | 22.78K | 70K | 66K | 0 | 0 | 0 | 0 | 0 |
Days Sales Outstanding | 54.93 | 75.41 | 191.19 | 122.84 | - | - | - | - | - | - |
Inventory | 1.42M | 957.35K | 171K | 184K | 284K | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | 8.7K | 2.49K | 653.13 | - | 2.21K | - | - | - | - | - |
Other Current Assets | 266.43K | 63.82K | 9.7K | 21.71K | 56K | 43K | 67K | 376K | 151K | 522K |
Total Non-Current Assets | 443.45K | 441.88K | 374.04K | 378K | 377K | 160K | 59K | 37K | 164K | 133K |
Property, Plant & Equipment | 240.45K | 216.75K | 149.78K | 321K | 315K | 109K | 40K | 27K | 154K | 133K |
Fixed Asset Turnover | 2.54x | 2.72x | 0.29x | 0.65x | - | - | - | - | - | 0.00x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 35.67K | 39.56K | 52.6K | 0 | 0 | 51K | 15K | 0 | 10K | 30K |
Other Non-Current Assets | 167.33K | 185.57K | 171.66K | 57K | 62K | 0 | 4K | 10K | 0 | 0 |
Total Assets | 2.46M▲ 0% | 1.67M▼ 32.2% | 688.19K▼ 58.8% | 1.1M▲ 59.3% | 10.61M▲ 867.7% | 6.26M▼ 40.9% | 2.44M▼ 61.1% | 4.91M▲ 101.2% | 5.93M▲ 20.9% | 10.21M▲ 0% |
Asset Turnover | 0.25x | 0.35x | 0.06x | 0.19x | - | - | - | - | - | 0.00x |
Asset Growth % | 15.39% | -32.18% | -58.76% | 59.26% | 867.7% | -40.93% | -61.09% | 101.19% | 20.94% | 1868.1% |
Total Current Liabilities | 2.35M | 3.69M | 3.22M | 2.27M | 1.34M | 883K | 1.01M | 1.51M | 1.27M | 3.08M |
Accounts Payable | 1.63M | 2.42M | 2.06M | 1.53M | 869K | 631K | 672K | 839K | 992K | 2.64M |
Days Payables Outstanding | 10.01K | 6.3K | 7.88K | - | 6.75K | - | 10.66K | 23.56K | 10.06K | 15.08K |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5K | 0 |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 363.74K | 336.78K | 239.96K | 195K | 244K | 0 | 341K | 673K | 252K | 414K |
Current Ratio | 0.86x | 0.33x | 0.10x | 0.32x | 7.61x | 6.91x | 2.35x | 3.22x | 4.52x | 3.27x |
Quick Ratio | 0.25x | 0.07x | 0.04x | 0.24x | 7.39x | 6.91x | 2.35x | 3.22x | 4.52x | 3.27x |
Cash Conversion Cycle | -1.26K | -3.73K | -7.04K | - | - | - | - | - | - | - |
Total Non-Current Liabilities | 11.06M | 14.56M | 339.88K | 236K | 279K | 227K | 195K | 196K | 17.66M | 245K |
Long-Term Debt | 162.03K | 182.77K | 168.22K | 191K | 197K | 210K | 195K | 196K | 203K | 221K |
Capital Lease Obligations | 0 | 0 | 0 | 45K | 82K | 17K | 0 | 0 | 33K | 118K |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 10.9M | 14.38M | 171.66K | 0 | 0 | 0 | 0 | 0 | 17.42M | 5K |
Total Liabilities | 13.41M | 18.24M | 3.56M | 2.51M | 1.62M | 1.11M | 1.21M | 1.71M | 18.93M | 3.33M |
Total Debt | 162.03K | 182.77K | 168.22K | 378K | 363K | 250K | 195K | 196K | 267K | 267K |
Net Debt | 13.2K | 128.99K | 71.14K | -41K | -9.46M | -5.81M | -2.12M | -4.3M | -5.35M | -9.29M |
Debt / Equity | - | - | - | - | 0.04x | 0.05x | 0.16x | 0.06x | - | 0.04x |
Debt / EBITDA | 0.03x | 0.02x | 0.03x | 0.11x | - | - | - | - | - | -0.02x |
Net Debt / EBITDA | 0.00x | 0.01x | 0.01x | -0.01x | - | - | - | - | - | 0.60x |
Interest Coverage | 348.78x | 433.51x | 357.50x | 350.60x | - | - | -1477.33x | - | -24.95x | -13.49x |
Total Equity | -10.95M▲ 0% | -16.57M▼ 51.4% | -2.87M▲ 82.7% | -1.41M▲ 50.9% | 8.98M▲ 736.1% | 5.16M▼ 42.6% | 1.23M▼ 76.1% | 3.2M▲ 159.9% | -13M▼ 506.6% | 6.88M▲ 0% |
Equity Growth % | -57.07% | -51.38% | 82.66% | 50.86% | 736.12% | -42.61% | -76.14% | 159.92% | -506.63% | 1460.49% |
Book Value per Share | -1.82 | -2.43 | - | -11.85 | 59.57 | 33.36 | 7.95 | 15.40 | -34.95 | 13.91 |
Total Shareholders' Equity | -10.95M | -16.57M | -2.87M | -1.41M | 8.98M | 5.16M | 1.23M | 3.2M | -13M | 6.88M |
Common Stock | 6.03K | 6.82K | 141.64K | 162K | 15K | 15K | 15K | 20K | 1K | 1K |
Retained Earnings | -35.6M | -47.37M | -87.19M | -90.7M | -93.4M | -97.47M | -101.9M | -109.85M | -132.45M | -144.04M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 62.58K | 110.67K | 164.23K | 124K | 15K | -6K | 17K | 64K | -8K | 41K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GCTK Cash Flow Statement
GlucoTrack, Inc. (GCTK) cash flow — operating, investing & free cash flow history
| Metric | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -5.31M | -5.9M | -4.89M | -3.9M | -3.5M | -3.77M | -3.73M | -6.56M | -12.49M | -14.32M |
Operating CF Margin % | -868.39% | -1000.08% | -11249.72% | -1874.56% | - | - | - | - | - | - |
Operating CF Growth % | -16.35% | -10.98% | 17.01% | 20.3% | 10.21% | -7.66% | 1.06% | -75.86% | -90.45% | -261.67% |
Net Income | -5.41M | -10.33M | -6.72M | -3.52M | -2.7M | -4.07M | -4.43M | -7.1M | -22.6M | -26.77M |
Depreciation & Amortization | 59.58K | 67.88K | 58.79K | 50.59K | 47K | 42K | 23K | 13K | 36K | 43K |
Stock-Based Compensation | 70.25K | 2.71M | 705.25K | 512.38K | 22K | 223K | 439K | 281K | 173K | 25K |
Deferred Taxes | -78.55K | -300.32K | 0 | 0 | 0 | 42K | 0 | 0 | 0 | 0 |
Other Non-Cash Items | -629 | 3.03K | -927 | 7.55K | 160K | 44K | 60K | 55K | 9.83M | 13.08M |
Working Capital Changes | 47.25K | 1.96M | 1.06M | -953.47K | -1.03M | -53K | 184K | 190K | 67K | -699K |
Change in Receivables | -73.44K | -19.27K | 89.31K | -44.04K | 10K | 68K | 0 | 0 | 0 | 0 |
Change in Inventory | -590.62K | 608.21K | 720.38K | 953 | -85K | 293K | 0 | 0 | 0 | 0 |
Change in Payables | 526.56K | 620.8K | -261.92K | -600.35K | -714K | -257K | 74K | 167K | 263K | 18K |
Cash from Investing | -76.45K | -19.47K | -5.37K | -23.43K | -53K | -1K | 1K | 0 | -104K | -42K |
Capital Expenditures | -76.45K | -19.47K | -5.37K | -23.43K | -53K | -5K | -1K | 0 | -104K | -42K |
CapEx % of Revenue | 12.5% | 3.3% | 12.35% | 11.27% | - | - | - | - | - | - |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | 0 | 4K | 2 | 0 | 0 | 0 |
Cash from Financing | 4.94M | 5.75M | 4.96M | 4.2M | 13.01M | 0 | 0 | 8.73M | 13.74M | 23.72M |
Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.38M | 4.36M |
Equity Issued (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 1000K | 1000K | 3M |
Dividends Paid | -13.53K | -5.73K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 1.64M | 1.95M | 2.26M | 33K | 0 | 0 | 0 | 0 | 85K | -143K |
Net Change in Cash | -459.87K▲ 0% | -95.05K▲ 79.3% | 56.34K▲ 159.3% | 326.03K▲ 478.7% | 9.41M▲ 2785.9% | -3.77M▼ 140.1% | -3.78M▼ 0.3% | 2.17M▲ 157.4% | 1.13M▼ 48.2% | 9.39M▲ 0% |
Free Cash Flow | -5.39M▲ 0% | -5.91M▼ 9.8% | -4.9M▲ 17.2% | -3.92M▲ 19.9% | -3.55M▲ 9.4% | -3.77M▼ 6.2% | -3.73M▲ 1.2% | -6.56M▼ 75.8% | -12.59M▼ 92.0% | -14.37M▲ 0% |
FCF Margin % | -880.89% | -1003.39% | -11262.07% | -1885.83% | - | - | - | - | - | - |
FCF Growth % | -14.43% | -9.77% | 17.19% | 19.91% | 9.4% | -6.19% | 1.17% | -75.82% | -92.04% | -55.97% |
FCF per Share | -0.89 | -0.87 | - | -32.91 | -23.57 | -24.43 | -24.10 | -31.59 | -33.86 | -29.05 |
FCF Conversion (FCF/Net Income) | 0.98x | 0.57x | 0.73x | 1.11x | 1.30x | 0.93x | 0.84x | 0.92x | 0.55x | 0.54x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 77K |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GCTK Key Ratios
GlucoTrack, Inc. (GCTK) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | - | - | - | -71.23% | -57.54% | -138.92% | -320.62% | - | -389.1% |
Return on Invested Capital (ROIC) | - | - | - | - | - | - | - | - | - | 188.94% |
Gross Margin | 90.26% | 76.21% | -119.75% | 100% | - | - | - | - | - | - |
Net Margin | -884.39% | -1752.24% | -15442.01% | -1690.38% | - | - | - | - | - | - |
Debt / Equity | - | - | - | - | 0.04x | 0.05x | 0.16x | 0.06x | - | 0.04x |
Interest Coverage | 348.78x | 433.51x | 357.50x | 350.60x | - | - | -1477.33x | - | -24.95x | -13.49x |
FCF Conversion | 0.98x | 0.57x | 0.73x | 1.11x | 1.30x | 0.93x | 0.84x | 0.92x | 0.55x | 0.54x |
Revenue Growth | 327.26% | -3.63% | -92.62% | 378.29% | -100% | - | - | - | - | - |
Related:GCTK Dividend History·GCTK Revenue History·GCTK Price History·GCTK P/E History·GCTK Financial Ratios·GCTK Institutional Holders
GCTK Frequently Asked Questions
GlucoTrack, Inc. (GCTK) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
GlucoTrack, Inc. (GCTK) grew revenue by 0.0% over the past year. Growth has been modest.
GlucoTrack, Inc. (GCTK) reported a net loss of $26.8M for fiscal year 2024.
Dividend & Returns
GlucoTrack, Inc. (GCTK) had negative free cash flow of $14.4M in fiscal year 2024, likely due to heavy capital investments.